Document is current
Any future updates will be listed below
-
Authors
Halegua, Thibaut https://orcid.org/0009-0006-5601-5238
Risson, Valérie https://orcid.org/0000-0002-6812-6297
Carras, Julien
Rouyer, Martin
Coudert, Laurent
Jacquier, Arnaud https://orcid.org/0000-0002-2883-9620
Schaeffer, Laurent https://orcid.org/0000-0001-6600-503X
Ohlmann, Théophile https://orcid.org/0000-0002-2001-8916
Mangeot, Philippe Emmanuel https://orcid.org/0000-0003-3819-5440
-
Funding
Funding for this research was provided by:
ANRS is agence nationale pour la recherche contre le sida et les hépatites virales (french academic funder). Work supported by grant ANRS0516 (TO).
- License Information
-
More Information
Article History
Received: 11 June 2024
Accepted: 17 December 2024
First Online: 4 January 2025
Competing interests
: T.H., P.E.M. and T.O. are inventors of two patents owned by Inserm Transfert EP N° EP24305987.0 and EP 24305808.8 protecting the molecular designs of constructs of the final Nanoscribes system. Patent application numbers are pending. The remaining authors declare no competing interests.
